Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Coherus BioSciences, Inc. (CHRS)

« Back to company index

CHRS Chatter Timeline

Stock Ticker for CHRS

Most Active Tweeters for CHRS

UserTweets
@kshahi 6
@larrywabrams 4
@AmericanBanking 2
@macondailynews 2
@TickerReport 2

Recent Tweets for CHRS

kshahi @kshahi
Are there any big pharmas with a biosimilar void who might want to buy out $CHRS ? Looking out and assuming pipelin… https://t.co/9qjT3VjN2J
June 17th 2019, 1:06pm
WKRBNews @WKRBNews
Head-To-Head Comparison: Cortexyme $CRTX vs. Coherus Biosciences $CHRS https://t.co/TTzUILNEZT #markets
June 17th 2019, 3:06am
macondailynews @macondailynews
Coherus Biosciences $CHRS Downgraded by BidaskClub to Buy https://t.co/JjUFE5T6Oe
June 15th 2019, 7:06am
TrdngDrivatives @TrdngDrivatives
RT @StockNewsWires: $CHRS $CEIX: Hedge Funds Have Never Been This Bullish On Coherus …: https://t.co/MOYbzbVA88
June 14th 2019, 6:06pm
StockNewsWires @StockNewsWires
$CHRS $CEIX: Hedge Funds Have Never Been This Bullish On Coherus …: https://t.co/MOYbzbVA88
June 14th 2019, 6:06pm
Gambiste1 @Gambiste1
RT @kshahi: $CHRS run up til earnings next month, then positive earnings surprise, then continuation upwards and onwards.
June 14th 2019, 5:06pm
Gambiste1 @Gambiste1
RT @ZG121015: $CHRS https://t.co/XC09NPaHC6
June 14th 2019, 5:06pm
kshahi @kshahi
$CHRS run up til earnings next month, then positive earnings surprise, then continuation upwards and onwards.
June 14th 2019, 3:06pm
ChartMill @ChartMill
$CHRS is expected to show a strong growth in EPS. In the coming 2 years, the EPS will grow by 64.45% yearly..… https://t.co/opupf1x9hv
June 14th 2019, 1:06pm
macondailynews @macondailynews
Barclays Initiates Coverage on Coherus Biosciences $CHRS https://t.co/FTS8OOBTsM
June 14th 2019, 10:06am
TickerReport @TickerReport
Coherus Biosciences $CHRS Downgraded by BidaskClub https://t.co/8ueNchyI7l
June 14th 2019, 8:06am
ZG121015 @ZG121015
$CHRS https://t.co/XC09NPaHC6
June 13th 2019, 8:06pm
harnek @harnek
Major milestones in the biosimilar story, ~20 approvals thus far Biosimilar pure-play $CHRS Coherus breakeven this… https://t.co/UpPskaplOt
June 13th 2019, 2:06pm
stevedoc22 @stevedoc22
@larrywabrams @caitlinnowens Not biased reporting. $CHRS -- Udenyca is 2/3 the cost of Neulasta Onpro - a savings o… https://t.co/TZe4Ih8OQk
June 13th 2019, 1:06pm
WeekHerald @WeekHerald
Coherus Biosciences $CHRS Lowered to Buy at BidaskClub https://t.co/AGBoQVeobr
June 13th 2019, 7:06am
TickerReport @TickerReport
Comparing Coherus Biosciences $CHRS and Cortexyme $CRTX https://t.co/exhr5fwHFy
June 12th 2019, 6:06pm
MaisaCorp @MaisaCorp
$CHRS Barclays Initiates Coverage on Coherus BioSciences With Overweight Rating and $30 PT
June 11th 2019, 3:06pm
kshahi @kshahi
$CHRS https://t.co/Sq1S1ESgIP
June 11th 2019, 10:06am
AmericanBanking @AmericanBanking
Barclays Initiates Coverage on Coherus Biosciences $CHRS https://t.co/ASznrG7hJt #stocks
June 11th 2019, 8:06am
firsttomarkets @firsttomarkets
Coherus Biosciences Inc Initiated Coverage by Barclays Capital (Ranked 33rd) to Overweight with $30PT $CHRS #CHRS https://t.co/65mrWY139z
June 11th 2019, 7:06am
Briefingcom @Briefingcom
$CHRS: Barclays starts at Overweight
June 11th 2019, 6:06am
AnalystWire @AnalystWire
Barclays Starts Coherus Biosciences $CHRS at Overweight https://t.co/3KXHWLkLVQ
June 11th 2019, 2:06am
stockmktgenius @stockmktgenius
$CHRS Coherus BioSciences, Inc. #LeaderPullBack Close: 17.26 Liq: $11M https://t.co/PM5S1zW6Uw
June 10th 2019, 8:06pm
OlympiaReport @OlympiaReport
Coherus Biosciences Inc $CHRS Receives $28.33 Consensus PT from Analysts https://t.co/WnJG02sd2T
June 10th 2019, 5:06pm
TradeFlags @TradeFlags
TD BUY $CHRS at 17.91, Supp 17.91 Resis 20.56 R15 HiLo 75% T1Y 29 buy 1.7 fwdPE -111.9 DIV N/A #Coherus Bi #stocks… https://t.co/iM2hAlMLwd
June 7th 2019, 10:06pm
larrywabrams @larrywabrams
@kshahi $CHRS audio of Jeffries presentation posted Friday June 7. CEO Lanfear very polished speaker. No specific… https://t.co/eW24HYlo6I
June 7th 2019, 9:06am
larrywabrams @larrywabrams
@kshahi $CHRS was scheduled to present at Jefferies Tuesday June 5th at 10 AM ET and post audio on website. Well,… https://t.co/NcIcEkbbEK
June 6th 2019, 11:06pm
ZolmaxNews @ZolmaxNews
Zacks: Analysts Anticipate Coherus Biosciences Inc $CHRS Will Post Earnings of -$0.21 Per Share https://t.co/4TkBJnP4mD
June 5th 2019, 5:06pm
kshahi @kshahi
From Jeffries fireside chat this morning, $CHRS looks to break even this year. Based on "area under the curve" calc… https://t.co/m7dVbASSux
June 5th 2019, 3:06pm
ConsumerFeed @ConsumerFeed
Coherus Biosciences Inc $CHRS Given Average Recommendation of “Buy” by Analysts https://t.co/KrxyCt7Pps
June 5th 2019, 8:06am
AmericanBanking @AmericanBanking
Coherus Biosciences Inc $CHRS Given Average Rating of “Buy” by Brokerages https://t.co/5WCjAvJnWS #stocks
June 5th 2019, 8:06am
kshahi @kshahi
Hope $CHRS updates weekly unit shipment numbers tomorrow at Jeffries conference. If trends continue, likely looking at significant upside.
June 4th 2019, 6:06pm
StockTexts @StockTexts
$CHRS Coherus BioSciences, Inc. SEC Filing: Form 4 https://t.co/3F74fWyXLc
June 4th 2019, 5:06pm
kshahi @kshahi
@larrywabrams @caitlinnowens This is a sign that $CHRS is making serious inroads with Udenyca. $AMGN now getting ne… https://t.co/hQ5PEZfZ0u
June 4th 2019, 11:06am
larrywabrams @larrywabrams
@caitlinnowens @axios Shoddy reporting on $AMGN Neulasta vs $CHRS Udencya. Failed to consider Neulasta now availab… https://t.co/MGq6D08qxP
June 4th 2019, 3:06am
larrywabrams @larrywabrams
[email protected]? Shoddy reporting on $AMGN Neulasta vs $CHRS Udencya. Failed to consider Neulasta now available as… https://t.co/6ZR31lodI8
June 4th 2019, 3:06am
TranscriptDaily @TranscriptDaily
-$0.21 Earnings Per Share Expected for Coherus Biosciences Inc $CHRS This Quarter https://t.co/TeIUL73i6X
June 3rd 2019, 12:06pm
InsiderAlertsIA @InsiderAlertsIA
$CHRS: New Insider Filing on President & CEO DENNIS M LANFEAR: https://t.co/CsDIhrQUxZ
June 3rd 2019, 6:06am
dailypoliticaln @dailypoliticaln
Coherus Biosciences Inc $CHRS CEO Dennis M. Lanfear Sells 32,398 Shares https://t.co/8EQ3VMLNaI
June 3rd 2019, 4:06am
ConsumerFeed @ConsumerFeed
Coherus Biosciences Inc $CHRS CEO Dennis M. Lanfear Sells 32,398 Shares https://t.co/evoE74arux
June 1st 2019, 11:06am
WKRBNews @WKRBNews
Analysts Expect Coherus Biosciences Inc $CHRS to Announce -$0.21 Earnings Per Share https://t.co/vSoGNZlOBl #markets
June 1st 2019, 5:06am
ConsumerFeed @ConsumerFeed
Coherus Biosciences CEO Dennis Lanfear Sells $631,437.02 in $CHRS https://t.co/S6VpZVfGSJ
June 1st 2019, 3:06am
stocknewstimes @stocknewstimes
Insider Selling: Coherus Biosciences Inc $CHRS CEO Sells 32,398 Shares of Stock https://t.co/CDxLVOwabI
May 31st 2019, 11:05pm
SleekMoneycom @SleekMoneycom
Insider Selling: Coherus Biosciences Inc $CHRS CEO Sells 32,398 Shares of Stock https://t.co/gWJARu2c3D #investing
May 31st 2019, 11:05pm
AmericanBanking @AmericanBanking
Coherus Biosciences Inc $CHRS CEO Sells $631,437.02 in Stock https://t.co/wSgsNSkrAD #stocks
May 31st 2019, 11:05pm
insiderbuyings @insiderbuyings
$CHRS new insider selling: 32398 shares. https://t.co/lh65m3bsZq
May 31st 2019, 9:05pm
StockTexts @StockTexts
$CHRS Coherus BioSciences, Inc. SEC Filing: Form 4 https://t.co/9ZR2wByBlU
May 31st 2019, 8:05pm
fintel_io @fintel_io
Insider Lanfear Dennis M reports selling 32,398 shares of $CHRS for a total cost of $631,281.51 https://t.co/TTwdcF7M6M
May 31st 2019, 8:05pm
confcalltran @confcalltran
Coherus BioSciences, Inc.'s President %26 CEO just disposed of 32,398 shares https://t.co/flztAViobz $CHRS
May 31st 2019, 8:05pm
RTFilingsStocks @RTFilingsStocks
Lanfear Dennis M files Form 4 for $CHRS Sold 32398 shares Price range: $19.4852-19.4852 Transaction Dates: 5/30/201… https://t.co/E6Sf48Zm6U
May 31st 2019, 8:05pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.